Susquehanna International »

Inhibikase Therapeutics shares owned by Susquehanna International

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by Susquehanna International

Quarter filed Position value Share count Share price at filing
2024-03-31 $49k 23k 2.16